Please be advised that Catalyst Biosciences, Inc. (CBIO), one of our affiliates, filed 8-K to SEC today regarding its listing status at Nasdaq.
For more details, please refer to the link below.
https://ir.catalystbiosciences.com/static-files/dcdd2465-4e87-4dba-b808-71ac4f404d45
This document is created purely for the purpose of publicly announcing CBIO's official filing with SEC and NOT for the purpose of soliciting investment either in Japan or overseas.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
GNI Group Limited published this content on 06 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 May 2023 00:30:06 UTC.